Cutaneous nociception and neurogenic inflammation evoked by PACAP38 and VIP.
Pituitary adenylate cyclase-activating peptide-38 (PACAP38) and vasoactive intestinal peptide (VIP) belong to the same secretin-glucagon superfamily and are present in nerve fibers in dura and skin. Using a model of acute cutaneous pain we explored differences in pain perception and vasomotor responses between PACAP38 and VIP in 16 healthy volunteers in a double-blind, placebo-controlled, crossover study. All participants received intradermal injections of 200 pmol PACAP38, 200 pmol VIP and placebo into the volar forearm. Measurements included pain intensity on a visual analog scale (VAS), blood flow by laser Doppler flowmetry, visual flare and wheal. Pain intensities after PACAP38 and VIP were mild and limited to a short time of about 100 s after injection. The area under the VAS-time curve was larger following PACAP38 (P = 0.004) and VIP (P = 0.01) compared to placebo. We found no statistical difference in pain perception between PACAP38 and VIP. Skin blood flow increase, flare and wheal were larger after both PACAP38 (P = 0.011) and VIP (P = 0.001) compared to placebo. VIP induced a considerably larger increase in skin blood flow, flare and wheal than PACAP38 (P = 0.002). In conclusion, we found that peripheral nociceptive cutaneous responses elicited by PACAP38 and VIP are similar in healthy volunteers. This suggests that acute pain and vasomotor responses following intradermal injections of PACAP38 and VIP are primarily mediated by VPAC receptors.
Schytz
Henrik Winther
HW
Department of Neurology, Faculty of Health Sciences, Danish Headache Center, Glostrup Hospital, University of Copenhagen, Glostrup 2600, Copenhagen, Denmark.
Holst
Helle
H
Arendt-Nielsen
Lars
L
Olesen
Jes
J
Ashina
Messoud
M
D000208:Acute Disease; D000279:Administration, Cutaneous; D000328:Adult; D018592:Cross-Over Studies; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008959:Models, Neurological; D020078:Neurogenic Inflammation / Q000139:chemically induced* / Q000378:metabolism / Q000473:pathology*; D009619:Nociceptors / Q000187:drug effects / Q000473:pathology*; D010146:Pain / Q000139:chemically induced* / Q000378:metabolism / Q000473:pathology*; D051219:Pituitary Adenylate Cyclase-Activating Polypeptide / Q000009:adverse effects*; D014660:Vasoactive Intestinal Peptide / Q000009:adverse effects*; D055815:Young Adult
D051219:Pituitary Adenylate Cyclase-Activating Polypeptide; D014660:Vasoactive Intestinal Peptide
Contact Dermatitis. 1996 Jul;35(1):1-10
8896947
Ann Neurol. 2000 May;47(5):614-24
10805332
Inflamm Res. 1998 Dec;47(12):488-92
9892043
Trends Pharmacol Sci. 1999 Aug;20(8):324-9
10431211
Pain. 2009 Jul;144(1-2):66-75
19423224
Br J Pharmacol. 1983 Apr;78(4):665-9
6133573
Cephalalgia. 2008 Mar;28(3):226-36
18254893
J Appl Physiol (1985). 1990 Dec;69(6):2149-54
1706332
Nature. 1996 Dec 12;384(6609):560-4
8955268
Neurology. 1993 Jun;43(6 Suppl 3):S16-20
8389008
Br J Clin Pharmacol. 2007 Nov;64(5):580-90
17578484
Clin J Pain. 1993 Jun;9(2):80-7
8358143
Physiol Rev. 2006 Oct;86(4):1309-79
17015491
J Orofac Pain. 2007 Fall;21(4):289-302
18018990
Exp Dermatol. 1999 Feb;8(1):39-45
10206720
Acta Histochem. 1997 Aug;99(3):301-9
9381913
J Endocrinol. 1993 Jan;136(1):159-66
8094091
Endocrinology. 1991 Nov;129(5):2787-9
1935809
J Neuroendocrinol. 1995 Jan;7(1):47-55
7735297
Brain Res Brain Res Rev. 2005 Jul;49(1):65-76
15960987
J Cutan Pathol. 2002 Feb;29(2):65-71
12150135
Cephalalgia. 2006 Aug;26(8):992-1003
16886936
Arch Dermatol Res. 1999 Apr;291(4):201-6
10335916
Neuroreport. 2000 Feb 28;11(3):645-8
10718329
Pain. 2005 Nov;118(1-2):155-63
16202522
Peptides. 1991 Mar-Apr;12(2):333-7
1712469
Cephalalgia. 2009 May;29(5):509-19
19187340
Pain. 2008 Sep 30;139(1):106-116
18450380
Brain. 2009 Jan;132(Pt 1):16-25
19052139
Acta Physiol Scand. 1989 Feb;135(2):95-105
2493712
Cephalalgia. 2010 Mar;30(3):337-45
19614687
J Neurophysiol. 1998 Feb;79(2):964-82
9463456
Cephalalgia. 2010 Feb;30(2):179-90
19614689
Pain. 2007 Jul;130(1-2):166-76
17459586
Acta Derm Venereol. 1996 May;76(3):205-9
8800300
Cephalalgia. 2002 Feb;22(1):54-61
11993614
Ann N Y Acad Sci. 2006 Jul;1070:239-42
16888173
Curr Pain Headache Rep. 2009 Jun;13(3):237-40
19457286
J Cardiovasc Pharmacol. 1992 Jul;20(1):83-7
1383635
Regul Pept. 1999 Mar 17;80(1-2):49-55
10235634
J Invest Dermatol. 1986 Oct;87(4):533-6
2428885
J Neurophysiol. 2006 Mar;95(3):1298-306
16492942
Neuroreport. 1995 Jul 31;6(11):1475-9
7579128
Peptides. 1990 Nov-Dec;11(6):1133-8
2087438
Regul Pept. 1995 Jan 26;55(2):133-48
7754101
Acta Derm Venereol. 1981;61(3):245-50
6167109
J Allergy Clin Immunol. 2003 May;111(5):1099-105
12743576
Ann N Y Acad Sci. 1998 Dec 11;865:141-6
9928006
Clin Allergy. 1987 Sep;17(5):469-79
2960474
Histochemistry. 1989;92(5):385-90
2531128
Peptides. 1989 Nov-Dec;10(6):1147-52
2482964
Cephalalgia. 1997 May;17(3):166-74
9170339